News | August 18, 2008

PAREXEL Closes The Acquisition Of ClinPhone

PAREXEL International Corporation, a leading global biopharmaceutical services organization, recently announced the successful closing of the acquisition of ClinPhone plc, a leading clinical technology organization. By combining ClinPhone with Perceptive Informatics, PAREXEL's wholly-owned technology subsidiary, Perceptive is now one of the industry's largest eClinical technology providers. The combined company offers unprecedented access to eClinical technologies and resources, providing clients and service providers with the benefits of an extensive line of products and services throughout the entire clinical development lifecycle.

Josef von Rickenbach, Chairman and Chief Executive Officer of PAREXEL International, said: "Biopharmaceutical companies require robust technology solutions to increase the efficiency and productivity of clinical research. This is especially important given the growing complexity and global nature of clinical studies today. We believe this acquisition further solidifies PAREXEL's leadership in providing integrated clinical and technology expertise. Combining the sophisticated, in-depth capabilities of Perceptive and ClinPhone represents a major step forward for PAREXEL in meeting increased industry demand for a truly comprehensive eClinical platform."

Steve Kent, former Chief Executive Officer of ClinPhone and newly- appointed President of Perceptive Informatics said: "Both companies bring tremendous capabilities to this deal. As a combined clinical technology company, Perceptive Informatics enables customers to benefit from the efficiency of best-in-class software and services from one source. Through the acquisition, Perceptive has a deeper level of resources as well as a broader range of technical and clinical expertise to drive greater innovation and meet the industry's evolving needs."

As a result of the transaction, Perceptive Informatics' comprehensive, industry-leading eClinical technology offering now includes:

  • ClinPhone Interactive Voice and Web Response Systems (IVRS/IWRS),
  • Perceptive Medical Imaging,
  • DataLabs, an Electronic Data Capture (EDC) and clinical data management system,
  • Clinical Trial Management Systems (CTMS):
  • IMPACT enterprise CTMS solution
  • TrialWorks CTMS solution for small and mid-size companies, and
  • Electronic Patient Reported Outcomes (ePRO).

Through the acquisition, Perceptive Informatics will further expand its technology integration and implementation services. These services help biopharmaceutical companies implement clinical trial process improvements, extend existing applications, and enable knowledge sharing across multiple systems.

PAREXEL plans to issue updated forward-looking financial guidance for the first quarter of Fiscal Year 2009 and for Fiscal Year 2009 in its entirety, through a press release to be issued after the close of the market on September 8, 2008. The Company plans to host a conference call to discuss the acquisition and the forward-looking guidance at 10:00 a.m. EDT on September 9, 2008.

About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 69 locations throughout 52 countries around the world, and has more than 8,800 employees. For more information about PAREXEL International visit www.PAREXEL.com.

SOURCE: PAREXEL International Corporation